N-苯基-2,3-萘二甲酰亚胺基 | 21815-18-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 中文名称: N-苯基-2,3-萘二甲酰亚胺基
• 英文名称: 2-phenyl-1H-benzo[f]isoindole-1,3(2H)-dione
• 英文别名: N-phenylnaphthalene-2,3-dicarboximide；N-phenyl-2,3-naphthalimide；2-phenyl-benzo[f]isoindole-1,3-dione；2-Phenyl-benz[f]isoindol-1,3-dion；2-phenyl-1H-benz[f]isoindole-1,3(2H)-dione；2-Phenyl-benzisoindolindion-(1,3)；2-Phenylbenzo[f]isoindole-1,3-dione
• CAS: 21815-18-9
• 化学式: C₁₈H₁₁NO₂
• 分子量: 273.291
• InChiKey: SAJVJIKFDFLINJ-UHFFFAOYSA-N

物化性质

• 熔点：
  278-284 °C

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  21
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2925190090
• 储存条件：
  将食品放入密封容器中，并存放在阴凉、干燥处。

SDS

Name:	N-Phenyl-2 3-naphthalimide 98% Material Safety Data Sheet
Synonym:	N-Phenylnaphthalene-2,3-dicarboximide; 2-Phenyl-1H-benz[f]isoindole-1,3(2H)-dion
CAS:	21815-18-9

Section 1 - Chemical Product MSDS Name:N-Phenyl-2 3-naphthalimide 98% Material Safety Data Sheet
Synonym:N-Phenylnaphthalene-2,3-dicarboximide; 2-Phenyl-1H-benz[f]isoindole-1,3(2H)-dion

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
21815-18-9	N-Phenyl-2,3-naphthalimide	98%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 21815-18-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Not available.
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C18H11NO2
Molecular Weight: 273.29

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Not available.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 21815-18-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-Phenyl-2,3-naphthalimide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 21815-18-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 21815-18-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 21815-18-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为产物：
  描述：

  3-(2-ethyl-butyryl)-[2]naphthoic acid 在 硝酸 、 溶剂黄146 作用下， 生成 N-苯基-2,3-萘二甲酰亚胺基
  参考文献：
  名称：

  Freund; Fleischer, Justus Liebigs Annalen der Chemie, 1913, vol. 402, p. 70

  摘要：

  DOI：

文献信息

• Medicinal composition
  申请人：Ishihara Sangyo Kaisha Ltd.

  公开号：US06429212B1

  公开（公告）日：2002-08-06

  It is to provide a cyclic imide derivative which is useful as an active ingredient of a pharmaceutical composition. A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): wherein Q1 is a single bond, —CH2—, —O—, —S— or —NH—, each of Q2 and Q3 is —C(O)—, —C(S)— or —CH2—, provided that at least one of Q2 and Q3 is —C(O)— or —C(S)—, Z is a single bond or a lower alkanediyl group, R is an aryl group which may be substituted or a cycloalkyl group which may be substituted, X is a nitro group, an amino group which may be acylated, a cyano group, a trifluoromethyl group, a hydroxyl group, a halogen atom, an alkyl group, an alkoxy group or an alkylthio group, m is an integer of from 0 to 4, and when m is 2 or above, X may be the same or different, or its salt.

  提供的是一种环状亚胺衍生物，它作为药物组合物的有效成分很有用。所述药物组合物包含由通式(I)表示的环状亚胺衍生物： 其中Q1是单键、-CH2-、-O-、-S-或-NH-，Q2和Q3每个是-C(O)-、-C(S)-或-CH2-，前提是Q2和Q3中至少有一个是-C(O)-或-C(S)-，Z是单键或低级脂肪二烯基团，R是可以被取代的芳基团或可以被取代的环烷基团，X是硝基团、可能被酰化的氨基团、氰基团、三氟甲基团、羟基团、卤素原子、烷基团、烷氧基团或烷硫基团，m是从0到4的整数，当m为2或以上时，X可以是相同的或不同的，或其盐。
• A Rhodium-Catalyzed Cascade Cyclization: Direct Synthesis of<i>N</i>-Substituted Phthalimides from Isocyanates and Benzoic Acids
  作者：Xian-Ying Shi、Andrea Renzetti、Soumen Kundu、Chao-Jun Li

  DOI：10.1002/adsc.201300834

  日期：2014.3.10

  A rhodium(III)‐catalyzed amidation between benzoic acids and isocyanates via direct functionalization of an ortho CH bond followed by intramolecular cyclization is described. This cascade cyclization affords N‐substituted phthalimides in one step in 26–91% yields. The reaction is highly atom‐economical, since no theoretical waste except for water is generated in the reaction.

  苯甲酸和异氰酸酯之间的铑（III）催化的酰胺化通过一个的直接官能邻Ç  H键，随后分子内环化进行说明。这种级联环化一步即可提供N取代的邻苯二甲酰亚胺，产率为26-91％。该反应是高度原子经济的，因为在反应中除水外没有产生理论上的浪费。
• Ruthenium(II)-catalyzed N-substituted phthalimide synthesis via C–H activation/[3+2] annulation
  作者：Xue-Fen Dong、Juan Fan、Xian-Ying Shi、Ke-Yan Liu、Peng-Min Wang、Jun-Fa Wei

  DOI：10.1016/j.jorganchem.2014.12.016

  日期：2015.3

  intermolecular [3 + 2] annulation pathway for aromatic acids with isocyanates to afford N-substituted phthalimide in one step is demonstrated, which provides an efficient process to direct preparation of phthalimide from commercially available starting materials and environmentally benign catalysts. This cascade cyclization involves the direct functionalization of an ortho C–H bond and the subsequent

  一步一步证明了钌催化的芳香酸与异氰酸酯的分子间[3 + 2]环化路径，可在一步中得到N-取代的邻苯二甲酰亚胺，它提供了一种有效的方法，可从市售的起始原料和环境友好的催化剂中直接制备邻苯二甲酰亚胺。这种级联环化涉及邻C–H键的直接功能化以及随后的分子内亲核取代。除了在反应中产生水以外，没有理论上的浪费。
• Murahashi et al., Nippon Kagaku Zasshi, 1958, vol. 79, p. 68,79
  作者：Murahashi et al.

  DOI：——

  日期：——
• Gilchrist, Thomas L.; Wood, Jane E., Journal of the Chemical Society. Perkin transactions I, 1992, # 1, p. 9 - 16
  作者：Gilchrist, Thomas L.、Wood, Jane E.

  DOI：——

  日期：——